冠心病合并糖尿病患者血运重建--CABG仍优于PCI——评CARDia研究1年随访结果

[1] Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients[J] . Akhil Kapur,Roger J. Hall,Iqbal S. Malik,Ayesha C. Qureshi,Jeremy Butts,Mark de Belder,Andreas Baumbach,Gianni Angelini,Adam de Belder,Keith G. Oldroyd,Marcus Flather,Michael Roughton,Petros Nihoyannopoulos,Jens Peder Bagger,Kenneth Morgan,Kevin J. Beatt.Journal of the American College of Cardiology . 2010 (5)

[2] Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease: Three-Year Follow-Up Results From a Single Institution[J] . Yan Li,Zhe Zheng,Bo Xu,Shiju Zhang,Wei Li,Runlin Gao,Shengshou Hu.Circulation . 2009 (15)

[3] Drug Eluting and Bare Metal Stents in People with and without Diabetes: Collaborative Network Meta-Analysis[J] . BMJ: British Medical Journal . 2008 (7671)

[4] Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease[J] . Aamir Javaid,Daniel H. Steinberg,Ashesh N. Buch,Paul J. Corso,Steven W. Boyce,Tina L. Pinto Slottow,Probal K. Roy,Peter Hill,Teruo Okabe,Rebecca Torguson,Kimberly A. Smith,Zhenyi Xue,Natalie Gevorkian,William O. Suddath,Kenneth M. Kent,Lowell F. Satler,Augusto D. Pichard,Ron Waksman.Circulation . 2007 (11 s)

[5] Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study[J] . Joost Daemen,Peter Wenaweser,Keiichi Tsuchida,Linda Abrecht,Sophia Vaina,Cyrill Morger,Neville Kukreja,Peter Jüni,Georgios Sianos,Gerrit Hellige,Ron T van Domburg,Otto M Hess,Eric Boersma,Bernhard Meier,Stephan Windecker,Patrick W Serruys.The Lancet . 2007 (9562)

[6] Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients[J] . Jacques Machecourt,Nicolas Danchin,Jean Marc Lablanche,Jean Marie Fauvel,Jean Louis Bonnet,Stephanie Marliere,Alison Foote,Jean Louis Quesada,Hélène Eltchaninoff,Gérald Vanzetto.Journal of the American College of Cardiology . 2007 (6)

[7] Management of coronary artery disease in patients with type 2 diabetes mellitus [J]. Current Cardiology Reports, 2007, 9 (4) : 264 - 271

[8] Rationale for the Revascularization Arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial[J] . Gregory W. Barsness,Bernard J. Gersh,Maria Mori Brooks,Robert L. Frye.The American Journal of Cardiology . 2006 (12)

[9] Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-Year Follow-Up of the e-Cypher Registry[J] . Philip Urban,Anthony H. Gershlick,Giulio Guagliumi,Philippe Guyon,Chaim Lotan,Joachim Schofer,Ashok Seth,J Eduardo Sousa,William Wijns,Claude Berge,Monika Deme,Hans-Peter Stoll.Circulation . 2006 (11)

[10] Optimal revasculariza-tion strategy in patients with three-vessel disease and/or left main disease:The2-year Outcomes of the SYNTAX Trial .2 Kappetein AP,Erasmus MC,Rotterdam NL. Eur Heart J . 2009

[1] Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients[J] . Akhil Kapur,Roger J. Hall,Iqbal S. Malik,Ayesha C. Qureshi,Jeremy Butts,Mark de Belder,Andreas Baumbach,Gianni Angelini,Adam de Belder,Keith G. Oldroyd,Marcus Flather,Michael Roughton,Petros Nihoyannopoulos,Jens Peder Bagger,Kenneth Morgan,Kevin J. Beatt.Journal of the American College of Cardiology . 2010 (5)

[2] Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease: Three-Year Follow-Up Results From a Single Institution[J] . Yan Li,Zhe Zheng,Bo Xu,Shiju Zhang,Wei Li,Runlin Gao,Shengshou Hu.Circulation . 2009 (15)

[3] Drug Eluting and Bare Metal Stents in People with and without Diabetes: Collaborative Network Meta-Analysis[J] . BMJ: British Medical Journal . 2008 (7671)

[4] Outcomes of Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention With Drug-Eluting Stents for Patients With Multivessel Coronary Artery Disease[J] . Aamir Javaid,Daniel H. Steinberg,Ashesh N. Buch,Paul J. Corso,Steven W. Boyce,Tina L. Pinto Slottow,Probal K. Roy,Peter Hill,Teruo Okabe,Rebecca Torguson,Kimberly A. Smith,Zhenyi Xue,Natalie Gevorkian,William O. Suddath,Kenneth M. Kent,Lowell F. Satler,Augusto D. Pichard,Ron Waksman.Circulation . 2007 (11 s)

[5] Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study[J] . Joost Daemen,Peter Wenaweser,Keiichi Tsuchida,Linda Abrecht,Sophia Vaina,Cyrill Morger,Neville Kukreja,Peter Jüni,Georgios Sianos,Gerrit Hellige,Ron T van Domburg,Otto M Hess,Eric Boersma,Bernhard Meier,Stephan Windecker,Patrick W Serruys.The Lancet . 2007 (9562)

[6] Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic Patients[J] . Jacques Machecourt,Nicolas Danchin,Jean Marc Lablanche,Jean Marie Fauvel,Jean Louis Bonnet,Stephanie Marliere,Alison Foote,Jean Louis Quesada,Hélène Eltchaninoff,Gérald Vanzetto.Journal of the American College of Cardiology . 2007 (6)

[7] Management of coronary artery disease in patients with type 2 diabetes mellitus [J]. Current Cardiology Reports, 2007, 9 (4) : 264 - 271

[8] Rationale for the Revascularization Arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial[J] . Gregory W. Barsness,Bernard J. Gersh,Maria Mori Brooks,Robert L. Frye.The American Journal of Cardiology . 2006 (12)

[9] Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-Year Follow-Up of the e-Cypher Registry[J] . Philip Urban,Anthony H. Gershlick,Giulio Guagliumi,Philippe Guyon,Chaim Lotan,Joachim Schofer,Ashok Seth,J Eduardo Sousa,William Wijns,Claude Berge,Monika Deme,Hans-Peter Stoll.Circulation . 2006 (11)

[10] Optimal revasculariza-tion strategy in patients with three-vessel disease and/or left main disease:The2-year Outcomes of the SYNTAX Trial .2 Kappetein AP,Erasmus MC,Rotterdam NL. Eur Heart J . 2009